RxDoctor Payments Data

Suzette Miller, NP

Psychiatric/Mental Health · Hazard, KYNPI 1780918573

Payments from drug & device makers

$1,021in general payments, 2019–2025

Across 61 payments — averaging $16.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$273
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$186
  • Indivior Inc.$152
  • Lundbeck LLC$120
  • Alkermes, Inc.$98
  • Otsuka America Pharmaceutical, Inc.$83
  • plus $108 from 5 others

What the payments were for

  • Food & beverage$1,021100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,021 in reported general payments places this provider in the 55th percentile of 946 psychiatric/mental health providers in Kentucky.

See all psychiatric/mental health providers in Kentucky

Medicare billing

Part B allowed, 2024
$18,513
Medicare patients
81
Services billed
463

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RexultiBrexpiprazole17$22,860
Risperdal ConstaRisperidone Microspheres16$10,115
Clozapine18$1,510
Aripiprazole11$504
Trazodone Hcl51$210
Clonazepam55$207
Prazosin Hcl20$188
Quetiapine Fumarate31$160
Mirtazapine22$124
Buspirone Hcl22$112
Paroxetine Hcl12$106
Propranolol Hcl11$103
Hydroxyzine Pamoate15$90
Venlafaxine Hcl ErVenlafaxine Hcl13$88
Risperidone13$83

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Otsuka America Pharmaceutical, Inc.Rexulti$83$22,86017 claims
Johnson & JohnsonRisperdal Consta$273$10,11516 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 946 psychiatric/mental health providers in Kentucky.

Other psychiatric/mental health in Hazard

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →